NanoViricides Capital Stock from 2010 to 2026
| NNVC Stock | USD 1.21 0.08 7.08% |
Capital Stock | First Reported 2010-12-31 | Previous Quarter 157.5 | Current Value 149.63 | Quarterly Volatility 40.2 K |
Check NanoViricides financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NanoViricides' main balance sheet or income statement drivers, such as Interest Expense of 179.9 M, Other Operating Expenses of 7.3 M or Research Development of 4.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.96 or PTB Ratio of 2.94. NanoViricides financial statements analysis is a perfect complement when working with NanoViricides Valuation or Volatility modules.
NanoViricides | Capital Stock | Build AI portfolio with NanoViricides Stock |
Latest NanoViricides' Capital Stock Growth Pattern
Below is the plot of the Capital Stock of NanoViricides over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. NanoViricides' Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NanoViricides' overall financial position and show how it may be relating to other accounts over time.
| Capital Stock | 10 Years Trend |
|
Capital Stock |
| Timeline |
NanoViricides Capital Stock Regression Statistics
| Arithmetic Mean | 45,427 | |
| Geometric Mean | 8,975 | |
| Coefficient Of Variation | 88.44 | |
| Mean Deviation | 38,737 | |
| Median | 82,012 | |
| Standard Deviation | 40,178 | |
| Sample Variance | 1.6B | |
| Range | 81.9K | |
| R-Value | (0.89) | |
| Mean Square Error | 368.1M | |
| R-Squared | 0.79 | |
| Slope | (7,055) | |
| Total Sum of Squares | 25.8B |
NanoViricides Capital Stock History
Other Fundumenentals of NanoViricides
NanoViricides Capital Stock component correlations
Click cells to compare fundamentals
About NanoViricides Financial Statements
NanoViricides stakeholders use historical fundamental indicators, such as NanoViricides' Capital Stock, to determine how well the company is positioned to perform in the future. Although NanoViricides investors may analyze each financial statement separately, they are all interrelated. For example, changes in NanoViricides' assets and liabilities are reflected in the revenues and expenses on NanoViricides' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in NanoViricides. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Capital Stock | 157.50 | 149.63 | |
| Issuance Of Capital Stock | 4.8 M | 5.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Check out the analysis of NanoViricides Correlation against competitors. For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoViricides. If investors know NanoViricides will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoViricides listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NanoViricides is measured differently than its book value, which is the value of NanoViricides that is recorded on the company's balance sheet. Investors also form their own opinion of NanoViricides' value that differs from its market value or its book value, called intrinsic value, which is NanoViricides' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoViricides' market value can be influenced by many factors that don't directly affect NanoViricides' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoViricides' value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoViricides is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoViricides' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.